CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-03-25 | Hadas Nicole R. See Remarks | Purchase | +3,500 | $17.00 | $60K | 76,123 |
| 2014-03-25 | Satter Muneer A Director | Conversion | +1,441,265 | 1,441,265 | ||
| 2014-03-25 | Satter Muneer A Director | Purchase | +91,295 | $17.00 | $1.6M | 1,532,560 |
| 2014-03-25 | Satter Muneer A Director | Conversion · Series B Convertible Preferred Stock | −260,873 | 0 | ||
| 2014-03-25 | Satter Muneer A Director | Conversion · Series C Convertible Preferred Stock | −525,021 | 0 | ||
| 2014-03-25 | Butler John P. President and CEO | Purchase | +13,850 | $17.00 | $235K | 13,850 |
| 2014-03-25 | Amello Jason SVP, CFO & Treasurer | Purchase | +4,000 | $17.00 | $68K | 4,000 |
| 2014-03-25 | Novo A/S 10% owner | Conversion | +1,333,797 | 1,333,797 | ||
| 2014-03-25 | Novo A/S 10% owner | Purchase | +182,590 | $17.00 | $3.1M | 1,516,387 |
| 2014-03-25 | Novo A/S 10% owner | Conversion · SERIES C PREFERRED STOCK | −714,285 | 0 |
Page 30 of 30 · 590 trades